These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
300 related items for PubMed ID: 16397218
1. Germ-line mutation of NKX3.1 cosegregates with hereditary prostate cancer and alters the homeodomain structure and function. Zheng SL, Ju JH, Chang BL, Ortner E, Sun J, Isaacs SD, Sun J, Wiley KE, Liu W, Zemedkun M, Walsh PC, Ferretti J, Gruschus J, Isaacs WB, Gelmann EP, Xu J. Cancer Res; 2006 Jan 01; 66(1):69-77. PubMed ID: 16397218 [Abstract] [Full Text] [Related]
2. A novel human prostate-specific, androgen-regulated homeobox gene (NKX3.1) that maps to 8p21, a region frequently deleted in prostate cancer. He WW, Sciavolino PJ, Wing J, Augustus M, Hudson P, Meissner PS, Curtis RT, Shell BK, Bostwick DG, Tindall DJ, Gelmann EP, Abate-Shen C, Carter KC. Genomics; 1997 Jul 01; 43(1):69-77. PubMed ID: 9226374 [Abstract] [Full Text] [Related]
3. Coding region of NKX3.1, a prostate-specific homeobox gene on 8p21, is not mutated in human prostate cancers. Voeller HJ, Augustus M, Madike V, Bova GS, Carter KC, Gelmann EP. Cancer Res; 1997 Oct 15; 57(20):4455-9. PubMed ID: 9377551 [Abstract] [Full Text] [Related]
4. Occurrence of NKX3.1 C154T polymorphism in men with and without prostate cancer and studies of its effect on protein function. Gelmann EP, Steadman DJ, Ma J, Ahronovitz N, Voeller HJ, Swope S, Abbaszadegan M, Brown KM, Strand K, Hayes RB, Stampfer MJ. Cancer Res; 2002 May 01; 62(9):2654-9. PubMed ID: 11980664 [Abstract] [Full Text] [Related]
5. Identification of an inhibitory cis-element in the promoter region of human homeobox gene NKX3.1. Anli J, Pengju Z, Xiaoyan H, Wenwei C, Zhifang L, Feng K, Huiqing Y, Jianye Z. Prostate; 2006 Sep 01; 66(12):1339-46. PubMed ID: 16845664 [Abstract] [Full Text] [Related]
6. Physical and functional interactions between the prostate suppressor homeoprotein NKX3.1 and serum response factor. Ju JH, Maeng JS, Zemedkun M, Ahronovitz N, Mack JW, Ferretti JA, Gelmann EP, Gruschus JM. J Mol Biol; 2006 Jul 28; 360(5):989-99. PubMed ID: 16814806 [Abstract] [Full Text] [Related]
10. Deletion, methylation, and expression of the NKX3.1 suppressor gene in primary human prostate cancer. Asatiani E, Huang WX, Wang A, Rodriguez Ortner E, Cavalli LR, Haddad BR, Gelmann EP. Cancer Res; 2005 Feb 15; 65(4):1164-73. PubMed ID: 15734999 [Abstract] [Full Text] [Related]
15. Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate cancer families with evidence of linkage to 17q markers. Zuhlke KA, Madeoy JJ, Beebe-Dimmer J, White KA, Griffin A, Lange EM, Gruber SB, Ostrander EA, Cooney KA. Clin Cancer Res; 2004 Sep 15; 10(18 Pt 1):5975-80. PubMed ID: 15447980 [Abstract] [Full Text] [Related]
17. Mechanisms of prostate tumorigenesis: roles for transcription factors Nkx3.1 and Egr1. Abdulkadir SA. Ann N Y Acad Sci; 2005 Nov 15; 1059():33-40. PubMed ID: 16382041 [Abstract] [Full Text] [Related]
19. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families. Durocher F, Labrie Y, Soucy P, Sinilnikova O, Labuda D, Bessette P, Chiquette J, Laframboise R, Lépine J, Lespérance B, Ouellette G, Pichette R, Plante M, Tavtigian SV, Simard J. BMC Cancer; 2006 Sep 29; 6():230. PubMed ID: 17010193 [Abstract] [Full Text] [Related]
20. Effect of homeodomain protein NKX3.1 R52C polymorphism on prostate gland size. Rodriguez Ortner E, Hayes RB, Weissfeld J, Gelmann EP. Urology; 2006 Feb 29; 67(2):311-5. PubMed ID: 16442598 [Abstract] [Full Text] [Related] Page: [Next] [New Search]